RNA, U6atac small nuclear 38, pseudogene (RNU6ATAC38P)

**RNA, U6atac small nuclear 38, pseudogene** (RNU6ATAC38P) is classified as a pseudogene in the human genome[3]. It is homologous to the functional U6atac small nuclear RNA (snRNA) genes, which code for a minor component of the spliceosome required for the removal of U12-type introns during pre-mRNA splicing[1][2]; however, as a *pseudogene*, RNU6ATAC38P is considered nonfunctional and does not produce an active snRNA. There are no known protein-coding nor regulatory roles, nor any associations with disease, biological functions, or drug interactions for this locus[3]. No evidence supports its role as a therapeutic target, biomarker, or relevant molecular entity for pharmacological intervention. **Key context and clarifications:** - RNU6ATAC38P should not be confused with functional small nuclear RNAs (such as U6atac or U4atac), which are essential for spliceosome function[1][2]. - By definition, a pseudogene has lost its gene function through mutation and is not transcribed into a functional molecule[3]. - There are no aliases, interacting drugs, nor is there any role in disease or molecular physiology documented in major databases[3]. - This locus is not considered a receptor, enzyme, transporter, or transcription factor. **Summary for structured data extraction:** RNU6ATAC38P is a nonfunctional pseudogene with no documented biological activity or druggability, and including it as a therapeutic target would be incorrect[3].

Other names

RNU6ATAC38P